Effect of Epigallocatechin Gallate Supplementation on Inflammation, Iron Status, and Metabolomic Profiles in Women With Obesity: A Pilot Randomized Controlled Trial
Molecular Nutrition & Food Research · 2026
DOI: 10.1002/mnfr.70575 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Molecular Nutrition & Food Research, 2026. Verfasst von Sixtus Aguree und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Health Science, Indiana University School of Public Health, Bloomington, Indiana, USA. Hauptthemen laut MEDLINE: Catechin, Obesity, Iron, Inflammation. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Doris A. Adams endowment chair funds from the Department of Food Science and Human Nutrition in the College of Human Sciences at Iowa State University.
Abstract (Originalsprache)
Obesity in women of reproductive age is often associated with low‐grade inflammation and functional iron deficiency. Epigallocatechin gallate (EGCG), a major green tea catechin, has antioxidant, anti‐inflammatory, and metabolic‐regulating properties but may also interfere with iron absorption. This randomized, double‐blind, placebo‐controlled pilot study evaluated the effects of EGCG on lipid profile, inflammation, iron status, and plasma metabolomics in women with obesity. Seventeen participants (BMI ≥30 kg/m 2 ; age 20–44 years) received 400 mg/day EGCG (green tea extract: 98% polyphenols, 60% catechins, ∼50% EGCG) or placebo for eight weeks. Outcomes included serum lipids, inflammatory markers (CRP, IL‐6, TNF‐α, IL‐10), iron indices (ferritin, hepcidin, serum iron, transferrin saturation), glucose, and metabolomics. No between‐group difference remained significant after correction for multiple comparisons. Total cholesterol (β = −10.9 mg/dL; p = 0.16) and LDL‐C (β = −9.7 mg/dL; p = 0.16) showed decreases, and IL‐6 the largest, though nonsignificant, reduction ( p = 0.09); other cytokines and glucose were unchanged. Metabolomics identified 29 nominally differential metabolites enriched in lipid metabolism, plasmalogen biosynthesis, and mitochondrial β‐oxidation, none surviving FDR correction. Iron status was stable. These findings suggest metabolic effects of EGCG and support short‐term safety at 400 mg/day. Larger, longer trials with targeted metabolomics are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Applied Health Science, Indiana University School of Public Health, Bloomington, Indiana, USA.
- Department of Food Science and Human Nutrition, Iowa State University, Ames, Iowa, USA.
- Department of Epidemiology and Biostatistics, Indiana University School of Public Health, Bloomington, Indiana, USA.
- Department of Kinesiology, Iowa State University, Ames, Iowa, USA.
Förderung
- Doris A. Adams endowment chair funds from the Department of Food Science and Human Nutrition in the College of Human Sciences at Iowa State University
Zitieren
APA
Aguree, S., Turi, K. N., Handt, A. R., Kohut, M., & Reddy, M. B. (2026). Effect of Epigallocatechin Gallate Supplementation on Inflammation, Iron Status, and Metabolomic Profiles in Women With Obesity: A Pilot Randomized Controlled Trial. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.70575
Vancouver
Aguree S, Turi KN, Handt AR, Kohut M, Reddy MB. Effect of Epigallocatechin Gallate Supplementation on Inflammation, Iron Status, and Metabolomic Profiles in Women With Obesity: A Pilot Randomized Controlled Trial. Molecular Nutrition & Food Research. 2026. doi:10.1002/mnfr.70575
BibTeX
@article{Aguree2026,
author = {Aguree, Sixtus and Turi, Kedir N and Handt, Alexandra R and Kohut, Marian and Reddy, Manju B},
title = {Effect of Epigallocatechin Gallate Supplementation on Inflammation, Iron Status, and Metabolomic Profiles in Women With Obesity: A Pilot Randomized Controlled Trial},
journal = {Molecular Nutrition & Food Research},
year = {2026},
doi = {10.1002/mnfr.70575}
}
EUVIMED